Companies / RetiSpec
RetiSpec
RetiSpec is a health and biotech AI company based in Toronto, Ontario. It raised a US$10M Series A in July 2024 led by iGan Partners.
AI analysis of hyperspectral retinal images to detect Alzheimer's disease pathology through an eye test.
retispec.com- Founded
- 2016
- Category
- Health/
Bio AI - Status
- Active
- Disclosed raised
- US$10M
Funding history
| Round | Date | Amount | Investors |
|---|---|---|---|
| Series A | Jul 26, 2024 | US$10M | iGan Partners (lead); Eli Lilly and Company, Topcon Healthcare, Gentex Corporation, Alzheimer's Drug Discovery Foundation Diagnostics Accelerator, Verge HealthTech Fund, Discovery Capital (University of Minnesota), Ontario Brain Institute, Centre for Aging + Brain Health Innovation. US$10M (C$13.8M) Series A announced Jul 26 2024 on PR Newswire; led by iGan Partners with new strategic investors Eli Lilly and Topcon Healthcare and returning Gentex, ADDF Diagnostics Accelerator, Verge HealthTech Fund, Discovery Capital, Ontario Brain Institute, CABHI and private investors; total raised US$17M |
Founders
- Eliav Shaked, Co-founder & CEO.
Sources
Data as of November 10, 2026.